Cytosorbents Corp
NASDAQ:CTSO
Balance Sheet
Balance Sheet Decomposition
Cytosorbents Corp
Cytosorbents Corp
Balance Sheet
Cytosorbents Corp
| May-2004 | May-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
0
|
3
|
2
|
1
|
1
|
2
|
2
|
4
|
5
|
5
|
17
|
22
|
12
|
71
|
52
|
22
|
14
|
3
|
|
| Cash Equivalents |
0
|
0
|
3
|
0
|
3
|
2
|
1
|
1
|
2
|
2
|
4
|
5
|
5
|
17
|
22
|
12
|
71
|
52
|
22
|
14
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
5
|
3
|
3
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
2
|
3
|
3
|
2
|
2
|
8
|
|
| Total Current Assets |
0
|
0
|
3
|
0
|
3
|
2
|
1
|
2
|
3
|
3
|
8
|
10
|
8
|
21
|
28
|
21
|
82
|
64
|
34
|
25
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
3
|
19
|
23
|
22
|
21
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
3
|
3
|
19
|
23
|
22
|
21
|
|
| Accumulated Depreciation |
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
0
|
4
|
4
|
5
|
2
|
3
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
0
|
3
|
4
|
5
|
4
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Total Assets |
0
N/A
|
0
-40%
|
3
+11 400%
|
1
-77%
|
3
+324%
|
2
-34%
|
2
-19%
|
2
+17%
|
3
+58%
|
4
+21%
|
8
+109%
|
11
+33%
|
10
-14%
|
24
+149%
|
34
+42%
|
27
-20%
|
90
+229%
|
90
0%
|
63
-29%
|
53
-16%
|
47
-11%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
4
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
6
|
8
|
6
|
5
|
5
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
1
|
4
|
1
|
2
|
0
|
0
|
0
|
3
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
1
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
3
|
4
|
8
|
7
|
10
|
10
|
14
|
10
|
14
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
9
|
13
|
0
|
0
|
5
|
3
|
14
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
13
|
13
|
13
|
12
|
|
| Total Liabilities |
0
N/A
|
0
+200%
|
1
+1 100%
|
1
-16%
|
1
+13%
|
1
-6%
|
2
+137%
|
2
-22%
|
2
+16%
|
3
+47%
|
5
+47%
|
3
-33%
|
8
+175%
|
14
+66%
|
17
+25%
|
24
+39%
|
11
-55%
|
27
+151%
|
28
+3%
|
29
+6%
|
36
+23%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
67
|
72
|
75
|
79
|
84
|
93
|
99
|
106
|
124
|
133
|
144
|
152
|
170
|
189
|
197
|
221
|
254
|
283
|
304
|
|
| Additional Paid In Capital |
0
|
0
|
70
|
71
|
78
|
80
|
83
|
93
|
87
|
91
|
128
|
140
|
144
|
163
|
186
|
192
|
278
|
283
|
287
|
306
|
311
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
2
|
1
|
2
|
1
|
4
|
|
| Total Equity |
0
N/A
|
0
N/A
|
2
N/A
|
0
N/A
|
2
N/A
|
1
-46%
|
0
N/A
|
0
N/A
|
1
+294%
|
1
-22%
|
4
+304%
|
8
+107%
|
1
-84%
|
10
+666%
|
17
+65%
|
3
-80%
|
79
+2 216%
|
63
-21%
|
35
-43%
|
23
-34%
|
11
-53%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-40%
|
3
+11 400%
|
1
-77%
|
3
+324%
|
2
-34%
|
2
-19%
|
2
+17%
|
3
+58%
|
4
+21%
|
8
+109%
|
11
+33%
|
10
-14%
|
24
+149%
|
34
+42%
|
27
-20%
|
90
+229%
|
90
0%
|
63
-29%
|
53
-16%
|
47
-11%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
3
|
5
|
7
|
9
|
10
|
23
|
25
|
25
|
29
|
32
|
33
|
43
|
43
|
44
|
54
|
55
|
|
| Preferred Shares Outstanding |
0
|
0
|
7
|
8
|
9
|
6
|
6
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|